Cargando…

Superior cervical gangliectomy induces non-exudative age-related macular degeneration in mice

Non-exudative age-related macular degeneration, a prevalent cause of blindness, is a progressive and degenerative disease characterized by alterations in Bruch's membrane, retinal pigment epithelium, and photoreceptors exclusively localized in the macula. Although experimental murine models exi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dieguez, Hernán H., Romeo, Horacio E., González Fleitas, María F., Aranda, Marcos L., Milne, Georgia A., Rosenstein, Ruth E., Dorfman, Damián
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Company of Biologists Ltd 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5894943/ https://www.ncbi.nlm.nih.gov/pubmed/29361515 http://dx.doi.org/10.1242/dmm.031641

Ejemplares similares

Enriched environment and visual stimuli protect the retinal pigment epithelium and photoreceptors in a mouse model of non-exudative age-related macular degeneration
por: Dieguez, Hernán H., et al.
Publicado: (2021)

Melatonin as a Therapeutic Resource for Inflammatory Visual Diseases
por: Aranda, Marcos L., et al.
Publicado: (2017)

A novel viewpoint in glaucoma therapeutics: enriched environment
por: González Fleitas, María F., et al.
Publicado: (2021)

Enriched Environment Protects the Optic Nerve from Early Diabetes-Induced Damage in Adult Rats
por: Dorfman, Damián, et al.
Publicado: (2015)

Environmental Enrichment Protects the Retina from Early Diabetic Damage in Adult Rats
por: Dorfman, Damián, et al.
Publicado: (2014)

Therapeutic Modalities of Exudative Age-related Macular Degeneration
por: Mavija, Milka, et al.
Publicado: (2014)

Early Signs of Exudative Age-Related Macular Degeneration in Asians
por: Sasaki, Mariko, et al.
Publicado: (2014)

Treatment of Exudative Age-related Macular Degeneration: Focus on Aflibercept
por: García-Layana, Alfredo, et al.
Publicado: (2015)

Unusual visual loss in a patient with exudative macular degeneration
por: Peng, Enoch T., et al.
Publicado: (2022)

Global and Ocular Hypothermic Preconditioning Protect the Rat Retina from Ischemic Damage
por: Salido, Ezequiel M., et al.
Publicado: (2013)

Optical Coherence Tomography-Based Deep-Learning Models for Classifying Normal and Age-Related Macular Degeneration and Exudative and Non-Exudative Age-Related Macular Degeneration Changes
por: Motozawa, Naohiro, et al.
Publicado: (2019)

Ischemic Conditioning Protects from Axoglial Alterations of the Optic Pathway Induced by Experimental Diabetes in Rats
por: Fernandez, Diego C., et al.
Publicado: (2012)

The Past, Present, and Future of Exudative Age-Related Macular Degeneration Treatment
por: Barak, Yoreh, et al.
Publicado: (2012)

Proteomics of Vitreous Humor of Patients with Exudative Age-Related Macular Degeneration
por: Koss, Michael Janusz, et al.
Publicado: (2014)

High-Density Lipoprotein Function in Exudative Age-Related Macular Degeneration
por: Pertl, Laura, et al.
Publicado: (2016)

Real-Life Data of Patients with Exudative Age-Related Macular Degeneration
por: Togac, Mesut, et al.
Publicado: (2021)

Unilateral macular exudation
por: Khanum, Aayesha, et al.
Publicado: (2021)

Clinical Wide-Field Retinal Image Deep Learning Classification of Exudative and Non-Exudative Age-Related Macular Degeneration
por: Tak, Nathaniel, et al.
Publicado: (2021)

Endothelin-1 and Nitric Oxide Levels in Exudative Age-Related Macular Degeneration
por: Totan, Yϋksel, et al.
Publicado: (2015)

Clinical and genetic characteristics of pachydrusen in patients with exudative age-related macular degeneration
por: Fukuda, Yoshiko, et al.
Publicado: (2019)

Correction: High-Density Lipoprotein Function in Exudative Age-Related Macular Degeneration
por: Pertl, Laura, et al.
Publicado: (2016)

Aflibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab
por: Hamid, Mohamed A., et al.
Publicado: (2021)

Exudative versus Nonexudative Age-Related Macular Degeneration: Physiopathology and Treatment Options
por: Fernandes, Ana Rita, et al.
Publicado: (2022)

Non-Neovascular Pachychoroid Disease Mimicking Exudative Age-Related Macular Degeneration
por: Kaseewat, Thachpacha, et al.
Publicado: (2021)

Long-term characteristics of exudative age-related macular degeneration in Japanese patients
por: Saito, Masaaki, et al.
Publicado: (2021)

Polymorphisms in CFI and ARMS genes and exudative age-related macular degeneration: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Effect of topical isopropyl unoprostone on macular atrophy progression in eyes with exudative age-related macular degeneration
por: Shiragami, Chieko, et al.
Publicado: (2017)

Diurnal variation of optical coherence tomography–based macular fluid in exudative age-related macular degeneration
por: Fortes, Blake H., et al.
Publicado: (2023)

Intravitreal treatment in patients with exudative age-related macular degeneration and visual acuity ≤ 0.05
por: Koch, Raphael, et al.
Publicado: (2015)

The Effect of Ranibizumab on Normal Neurosensory Retina in the Eyes of Patients with Exudative Age Related Macular Degeneration
por: Makri, Olga E., et al.
Publicado: (2017)

Cone photoreceptor macular function and recovery after photostress in early non-exudative age-related macular degeneration
por: Rodriguez, John D, et al.
Publicado: (2018)

Comparing the Effectiveness of Bevacizumab to Ranibizumab in Patients with Exudative Age-Related Macular Degeneration. The BRAMD Study
por: Schauwvlieghe, A. M. E., et al.
Publicado: (2016)

Combined treatment of exudative age related macular degeneration with photodynamic therapy and intravitreal triamcinolone
por: Ruiz-Moreno, José Mª, et al.
Publicado: (2008)

The effect of ranibizumab versus photodynamic therapy on DNA damage in patients with exudative macular degeneration
por: Mozaffarieh, M, et al.
Publicado: (2009)

Visual outcome of intravitreal ranibizumab for exudative age-related macular degeneration: timing and prognosis
por: Canan, Handan, et al.
Publicado: (2014)

Effects of switching from ranibizumab to aflibercept in eyes with exudative age-related macular degeneration
por: Barthelmes, Daniel, et al.
Publicado: (2016)

Treatment of retinal pigment epithelial detachment secondary to exudative age-related macular degeneration
por: Gonzalez, Andres, et al.
Publicado: (2017)

EXIT STRATEGY IN A TREAT-AND-EXTEND REGIMEN FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION
por: Arendt, Petra, et al.
Publicado: (2019)

Results of switchback from ranibizumab to aflibercept in patients with exudative age-related macular degeneration
por: Koike, Naoko, et al.
Publicado: (2019)

Decreased Circulating Levels of Dickkopf-1 in Patients with Exudative Age-related Macular Degeneration
por: Qiu, Fangfang, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_oqkp843vs6b0g5vp9r36nbme53